Five things for pharma marketers to know on Wednesday, May 23, 2018

Keytruda passes late-stage trial; Astellas to cut 600 jobs in restructuring; Teva expects FDA decision on migraine drug by mid-September.

from Most popular articles from Medical Marketing and Media https://ift.tt/2s78md7